Pharmaceutical/Biotech: R&D Alliances

AdvanceTech Monitor
May 1, 2001
355 Pages - SKU: ATM490291
License type:
Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

Pharmaceutical/Biotech: R and D Alliances
  • Executive Summary (pp. 9-16) US $81.00
  • Introduction (pp. 17-27) US $95.00
  • Key Terms and Provisions of Pharmaceutical/Biotechnology Alliance Agreements (pp. 28-37) US $98.00
  • New-Technology Valuation and Licensing Agreements (pp. 38-67) US $276.00
  • Web-Based Technology Licensing and Electronic Contracting (pp. 68-83) US $134.00
  • Aspects of Platform Technology Collaborations (pp. 84-94) US $107.00
  • Equity-Based Partnerships (pp. 95-110) US $143.00
  • Pharmaceutical/Biotech Alliances: Lessons Learned from the Computer Industry (pp. 111-132) US $175.00
  • Development and Management of Pharmaceutical/Biotech Alliances (pp. 133-154) US $191.00
  • The Role of the Alliance Manager (pp. 155-160) US $50.00
  • Implementing Healthy Strategic Alliances (pp. 161-170) US $82.00
  • Virtual Management of R&D Alliances (pp. 171-180) US $87.00
  • Managing a Large Number of Alliances (pp. 181-195) US $124.00
  • The SNP Consortium (pp. 196-210) US $124.00
  • The Consortium as a Financial and Business Model (pp. 211-219) US $81.00
  • Managing Multiparty Alliances (pp. 220-240) US $180.00
  • Using FDA Databases and Computational Models in Regulatory and R& D Decision- Making (pp. 241-252) US $106.00
  • Enabling High-Risk R&D Alliances: The Advanced Technology Program (pp. 253-268) US $131.00
  • Successful Collaboration with Universities (pp. 269-289) US $167.00
  • Millennium s Alliances: Focusing on Applications of Genomic-Type Technologies (pp. 290-301) US $93.00
  • The Triangle Pharmaceuticals/Abbott Laboratories Strategic Portfolio Alliance (pp. 302-308) US $58.00
  • Vertex Pharmaceuticals Alliances: Focusing on Drug Targets Structural Similarity (pp. 309-314) US $48.00
  • Sequenom s Collaborations: Successful Licensing of a Platform Technology (pp. 315-321) US $55.00
  • Value Creation in R&D Alliances: A Case Study of Lilly s Genomics Consortium with Academic Partners (pp. 322-334) US $121.00
  • Moving Toward More Equal Pharmaceutical/Biotechnology R&D Partnerships (pp. 335-338) US $48.00
  • Wall Street s View of Biotechnology and Pharmaceutical Partnerships (pp. 339-357) US $154.00


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Research & Development Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!